Sean Colm Turner

USPTO Granted Patents = 49 (Patent Applications = 13)

CIPO Patents = 14 (Patent Applications = 12)

EPO Patents = 23 (Patent Applications = 24)

Average Co-Inventor Count = 7.3

ph-index = 8

Forward Citations = 193(Granted Patents)

Location History:

Mannheim, GB (2010)
Evanston, IL (US) (2005 - 2012)
Wiesbaden, DE (2016 - 2017)
Mannheim, DE (2006 - 2018)
Ludwigshafen, DE (2012 - 2020)

Company Filing History:

20 out of 150

Abb Vie Deutschland Gmbh & Co. Kg

Abbott Laboratories Corporation

patents

where one patent can have more than one assignee

Years Active: 2005-2020

Loading Chart...

49 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10556914 - Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of use (2020-02-11),

2. 10556907 - Fused heterocyclic compounds as S1P modulators (2020-02-11),

3. 10155770 - Substituted pyrazolopyrimidines and method of use (2018-12-18),

4. 10100048 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors (2018-10-16),

5. 9879033 - Modulators of 5-HT receptors and methods of use thereof (2018-01-30),

6. 9856234 - Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors (2018-01-02),

7. 9828381 - Substituted pyrazolopyrimidines and method of use (2017-11-28),

8. 9790203 - Inhibitor compounds of phosphodiesterase type 10A (2017-10-17),

9. 9657034 - Substituted furo[3,2-c]pyridines, thieno[3,2-c]pyridines, thieno[2,3-d]pyridazines and pyrido[3,4-d]pyridazines as phosphodiesterase type 10A inhibitors (2017-05-23),

10. 9540370 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors (2017-01-10),

11. 9273068 - Substituted isoquinolines and phthalazines as inhibitors of phosphodiesterase type 10A (2016-03-01),

12. 9266855 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors (2016-02-23),

13. 9238619 - Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy (2016-01-19),

14. 9187483 - Modulators of 5-HT receptors and methods of use thereof (2015-11-17),

15. 9163007 - 5-substituted indazoles as kinase inhibitors (2015-10-20),

Title: Sean Colm Turner: Pioneering Innovations in Mannheim

Introduction: Sean Colm Turner, a visionary inventor based in Mannheim, Germany, has left an indelible mark on the world of technology through his relentless pursuit of innovation. With a total of 49 patents to his name, Turner continues to inspire the next generation of inventors and shape the future of technology.

Latest Patents: Among Turner's latest patents are groundbreaking inventions that have the potential to revolutionize the field of pharmaceuticals. One of his patents focuses on fused heterocyclic compounds as S1P modulators, which have shown promising results in the treatment, alleviation, or prevention of diseases mediated by an S1P receptor. Another patent highlights substituted isoxazolopyridazinones and isothiazolopyridazinones, which exhibit positive allosteric modulation of the GABA-B receptor, offering new possibilities for treating various conditions.

Career Highlights: Throughout his illustrious career, Sean Colm Turner has made significant contributions to the field of biopharmaceuticals through his innovative research and patented inventions. With a strong focus on drug development and therapeutic interventions, Turner has paved the way for novel treatment approaches that address unmet medical needs.

Collaborations: Turner's collaborative efforts have further enriched his inventive journey. Working alongside talented individuals such as Karla Drescher and Wilfried Martin Braje, Turner has harnessed the power of teamwork to bring his innovative concepts to fruition. Collaborations with companies like AbbVie Deutschland GmbH & Co. KG and Abbott GmbH & Co. KG have provided Turner with valuable resources and support to advance his inventions.

Conclusion: Sean Colm Turner's unwavering dedication to innovation and his trailblazing spirit serve as a beacon of inspiration for aspiring inventors worldwide. His contributions to the field of technology and pharmaceuticals underscore the transformative power of creativity and perseverance. As Turner continues to push the boundaries of innovation, his impact on shaping the future of technology remains profound and enduring.

This text is generated by artificial intelligence and may not be accurate.